Implantable cardioverter defibrillator having fast action operation

• US 6,931,278 B1
• Filed: 12/06/2002
• Issued: 08/16/2005
• Est. Priority Date: 12/06/2002
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Kroll, Mark W., Mouchawar, Gabriel A., Fayram, Timothy A.
• Primary Examiner(s): Getzow, Scott M.
• Application Number:
  US10/313,223
• Time in Patent Office: 984 Days
• Field of Search: 607 4- 8
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence

Abstract

An implantable cardiac rhythm management device has a housing containing rhythm management circuitry. The circuitry includes a battery, a transformer, and a capacitor connected via charging circuitry that operates to transmit current from the battery to charge the capacitor. A number of leads connected to the circuitry operate to transmit a shock from the capacitor to cardiac tissue outside of the housing. The capacitor has a smaller volume than the combined volume of the battery and transformer, such that it reaches a selected charge voltage within a limited time interval. The device may operate to limit capacitor charging to less than a selected energy storage capability at a given voltage, and components may be selected to limit charging time to less than 2 seconds. The component selection and charge duration may be based on a time-based function of defibrillation threshold (DFT).

Claims

1. An implantable cardiac rhythm management device, comprising:

a housing containing rhythm management circuitry;

the circuitry including a battery, a transformer, and a single capacitor connected via charging circuitry operable to transmit current from the battery to charge the single capacitor;

a plurality of electrodes connected to the circuitry and operable to transmit a shock from the single capacitor to cardiac tissue outside of the housing; and

the combined volume of the battery and transformer being at least 1.5 times the volume of the single capacitor.

2. The device of claim 1 wherein the devices contains only a single battery.

3. The device of claim 1 wherein the capacitor has a capacitance of less than 50 μ

F.

4. The device of claim 1 wherein the battery charging power is greater than 4 watts.

5. The device of claim 1 wherein the capacitor has a volume less than 5 ml.

6. The device of claim 1 wherein the battery and capacitor are sized such that the battery is operable to charge the capacitor to at least 700 volts within 2 seconds.

7. The device of claim 1 wherein the battery and capacitor are sized based on a function of DFT levels with respect to time interval to deliver therapy.

8. The device of claim 1 wherein the battery and capacitor are sized to provide a safety margin ratio of delivered energy to DFT in the range of a local maximum at less than a selected charge time interval.

9. An implantable cardiac rhythm management device, comprising:

a housing containing rhythm management circuitry;

the circuitry including a battery, a transformer, and a single capacitor connected via charging circuitry operable to transmit current from the battery to charge the single capacitor;

a plurality of electrodes connected to the circuitry and operable to transmit a shock from the single capacitor to cardiac tissue outside of the housing;

the single capacitor having a capacitance of less than 50 μ

F; and

the charge circuitry operable to charge the single capacitor to a voltage of at least 700 volts.

10. The device of claim 9 wherein the combined volume of the battery and transformer is at least 1.5 times the volume of the capacitor.

11. The device of claim 9 wherein the combined volume of the battery and transformer is between 1.5 and 2.5 times the volume of the capacitor.

12. The device of claim 9 wherein the battery is greater than 4 watts.

13. The device of claim 9 wherein the capacitor has a volume less than 5 ml.

14. The device of claim 9 wherein the battery and capacitor are sized such that the battery is operable to charge the capacitor to at least 700 volts within 2 seconds.

15. The device of claim 9 wherein the battery and capacitor are sized based on a function of DFT levels with respect to time interval to deliver therapy.

16. The device of claim 9 wherein the battery and capacitor are sized to provide a safety margin ratio of energy to DFT in the range of a local maximum at less than a selected charge time interval.

17. A method of operating an implantable cardiac rhythm management device having detection circuitry, a battery and a transformer connected via charging circuitry, the method comprising:

in response to an abnormality detected by the detection circuitry, generating current flow from the battery to a single capacitor to charge the single capacitor;

generating the current flow during a charging interval having a limited selected duration based on a DFT time function; and

discharging the single capacitor to deliver a therapeutic shock after the charging interval;

wherein the combined volume of the battery and transformer being at least 1.5 times the volume of the single capacitor.

18. The method of claim 17 wherein the charging interval is less than 2 seconds.

19. The method of claim 17 wherein the DFT time function provides that DFT decreases with a decreasing time interval for times below a selected time threshold, and wherein the charging interval is less than the time threshold.

20. The method of claim 17 wherein generating the current flow includes charging the capacitor to at least 700 volts.